Ulrik Jurva

2.0k total citations
39 papers, 1.6k citations indexed

About

Ulrik Jurva is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Ulrik Jurva has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Pharmacology and 11 papers in Organic Chemistry. Recurrent topics in Ulrik Jurva's work include Pharmacogenetics and Drug Metabolism (14 papers), Computational Drug Discovery Methods (8 papers) and Analytical Chemistry and Chromatography (6 papers). Ulrik Jurva is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Computational Drug Discovery Methods (8 papers) and Analytical Chemistry and Chromatography (6 papers). Ulrik Jurva collaborates with scholars based in Sweden, Australia and Netherlands. Ulrik Jurva's co-authors include Lars Weidolf, Andries P. Bruins, Håkan Wikström, Tove Johansson, Christian Skonberg, Jørgen Olsen, K. Madsen, Steen Honoré Hansen, Emre M. Isin and Gunnar Grönberg and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Ulrik Jurva

37 papers receiving 1.6k citations

Peers

Ulrik Jurva
Manjunath S. Shet United States
John Comer United Kingdom
Hanlan Liu United States
Sandeep Modi United Kingdom
Hayley C. Angove United States
Shuguang Ma United States
Manjunath S. Shet United States
Ulrik Jurva
Citations per year, relative to Ulrik Jurva Ulrik Jurva (= 1×) peers Manjunath S. Shet

Countries citing papers authored by Ulrik Jurva

Since Specialization
Citations

This map shows the geographic impact of Ulrik Jurva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrik Jurva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrik Jurva more than expected).

Fields of papers citing papers by Ulrik Jurva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrik Jurva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrik Jurva. The network helps show where Ulrik Jurva may publish in the future.

Co-authorship network of co-authors of Ulrik Jurva

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrik Jurva. A scholar is included among the top collaborators of Ulrik Jurva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrik Jurva. Ulrik Jurva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Isabella, Anja Ekdahl, Cecilia Ericsson, et al.. (2025). Metabolite Identification Data in Drug Discovery, Part 1: Data Generation and Trend Analysis. Molecular Pharmaceutics. 22(11). 6788–6802. 1 indexed citations
2.
Jurva, Ulrik, Jong Min Baek, Raine E. S. Thomson, et al.. (2024). Biocatalysis using Thermostable Cytochrome P450 Enzymes in Bacterial Membranes – Comparison of Metabolic Pathways with Human Liver Microsomes and Recombinant Human Enzymes. Drug Metabolism and Disposition. 52(3). 242–251. 1 indexed citations
3.
Jurva, Ulrik, Lars Weidolf, Anja Ekdahl, et al.. (2023). Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans. Drug Metabolism and Disposition. 51(4). 464–479. 6 indexed citations
4.
Thomson, Raine E. S., Yosephine Gumulya, Gabriel Foley, et al.. (2022). Ancestral Sequence Reconstruction of a Cytochrome P450 Family Involved in Chemical Defense Reveals the Functional Evolution of a Promiscuous, Xenobiotic-Metabolizing Enzyme in Vertebrates. Molecular Biology and Evolution. 39(6). 19 indexed citations
5.
Baek, Jong Min, et al.. (2020). An Inexpensive, Efficient Alternative to NADPH to Support Catalysis by Thermostable Cytochrome P450 Enzymes. ChemCatChem. 12(6). 1750–1761. 6 indexed citations
6.
Voss, James J. De, et al.. (2020). Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 48(6). 432–437. 10 indexed citations
7.
Kajanus, Johan, Thomas Antonsson, Leif Carlsson, et al.. (2019). Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 29(10). 1241–1245. 7 indexed citations
8.
Baek, Jong‐Min, Raine E. S. Thomson, Dominic J. B. Hunter, et al.. (2018). Engineering highly functional thermostable proteins using ancestral sequence reconstruction. Nature Catalysis. 1(11). 878–888. 138 indexed citations
9.
Gumulya, Yosephine, Raine E. S. Thomson, Dominic J. B. Hunter, et al.. (2018). Engineering Thermostable CYP2D Enzymes for Biocatalysis Using Combinatorial Libraries of Ancestors for Directed Evolution (CLADE). ChemCatChem. 11(2). 841–850. 18 indexed citations
10.
Fjellström, Ola, Hans‐Georg Beisel, Per‐Olof Eriksson, et al.. (2015). Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design. PLoS ONE. 10(1). e0113705–e0113705. 27 indexed citations
11.
Buckett, Linda K., Öjvind Davidsson, Hans Emtenäs, et al.. (2013). Identification and design of a novel series of MGAT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2721–2726. 25 indexed citations
12.
Jurva, Ulrik, et al.. (2012). The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold. Bioorganic & Medicinal Chemistry Letters. 22(24). 7302–7305. 15 indexed citations
13.
Weidolf, Lars, et al.. (2010). P450‐catalyzed vs. electrochemical oxidation of haloperidol studied by ultra‐performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry. 24(9). 1231–1240. 27 indexed citations
14.
Johansson, Tove, et al.. (2009). In Vitro Metabolism of Haloperidol and Sila-Haloperidol: New Metabolic Pathways Resulting from Carbon/Silicon Exchange. Drug Metabolism and Disposition. 38(1). 73–83. 63 indexed citations
15.
Afzelius, Lovisa, Catrin Hasselgren Arnby, Anders Broo, et al.. (2007). State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications. Drug Metabolism Reviews. 39(1). 61–86. 88 indexed citations
16.
Tacke, Reinhold, Bárbara Müller, Christian Burschka, et al.. (2007). Sila‐Haloperidol, a Silicon Analogue of the Dopamine (D 2 ) Receptor Antagonist Haloperidol: Synthesis, Pharmacological Properties, and Metabolic Fate. ChemMedChem. 3(1). 152–164. 77 indexed citations
17.
Permentier, Hjalmar P., Ulrik Jurva, Begoña Barroso, & Andries P. Bruins. (2003). Electrochemical oxidation and cleavage of peptides analyzed with on‐line mass spectrometric detection. Rapid Communications in Mass Spectrometry. 17(14). 1585–1592. 71 indexed citations
18.
Jurva, Ulrik, Håkan Wikström, Lars Weidolf, & Andries P. Bruins. (2003). Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions. Rapid Communications in Mass Spectrometry. 17(8). 800–810. 178 indexed citations
19.
Jurva, Ulrik, Håkan Wikström, & Andries P. Bruins. (2002). Electrochemically assisted Fenton reaction: reaction of hydroxyl radicals with xenobiotics followed by on‐line analysis with high‐performance liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 16(20). 1934–1940. 55 indexed citations
20.
Jurva, Ulrik, et al.. (2000). In vitro mimicry of metabolic oxidation reactions by electrochemistry/mass spectrometry. Rapid Communications in Mass Spectrometry. 14(6). 529–533. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026